By Josh Beckerman

 

Regeneron Pharmaceuticals Inc.'s Covid-19 antibody cocktail has received an expanded Emergency Use Authorization from the Food and Drug Administration.

The expanded authorization enables use of REGEN-COV for post-exposure prophylaxis in certain people exposed to a SARS-CoV-2 infected individual, or who are at high risk of exposure to an infected person in an institutional setting.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

July 30, 2021 14:13 ET (18:13 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more Regeneron Pharmaceuticals Charts.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more Regeneron Pharmaceuticals Charts.